Bcl-2 specific siRNA reported to specifically inhibit the expression of target gene in vitro and in vivo with anti-proliferative and pro-apoptotic effects observed in pancreatic carcinoma cells. This evidence concerns the gene BCL2 and exocrine pancreatic carcinoma.